Beschreibung
Combining duloxetine and sertraline, two serotonergic antidepressants, markedly increases the risk of serotonin syndrome without added efficacy.
Mechanismus
Both agents inhibit SERT; duloxetine additionally inhibits NET, resulting in robust serotonergic and noradrenergic excess when combined.
Klinische Bedeutung
Dual antidepressant therapy of this type is not evidence-based and carries significant serotonin toxicity risk.
Maßnahmen
Avoid concurrent use; if augmentation is needed, consult a psychiatrist for evidence-based strategies.
Medizinischer Haftungsausschluss
This content is for educational and informational purposes only. It is not a substitute for professional medical advice, diagnosis, or treatment. Always consult a qualified healthcare provider before making medication decisions.